A retrospective study evaluates growth patterns in ascending aortic dilation, indicating the need for revised surveillance strategies.
ABSTRACT Background Predicting ascending aortic (AsAo) growth is challenging. Linear, continuous assumptions may oversimplify biology. We evaluated: (1) whether baseline body size–indexed diameter has a non-linear association with subsequent growth; and (2) whether patient-level trajectories are continuous or episodic. Methods Single-center, retrospective study (2012–2024). The Primary Cohort (n=3,315; ≥2 CT/MR scans) modeled the association between baseline indexed size (Z-score) and annualized growth using multivariable linear regression and generalized additive models (GAMs), adjusting for clinical covariates. A Sub-Cohort (n=1,055; ≥4 scans) was classified into longitudinal phenotypes: Stable (Total Growth <2.0 mm), Stable-with-Noise (Total Growth <2.0 mm with alternating small changes), Continuous Growth (Total Growth ≥2.0 mm without an episodic event), and Discontinuous/Episodic Growth (Total Growth ≥2.0 mm with ≥1 growth episode, defined as a diameter increase ≥2.0 mm within one interval or across two adjacent intervals). Results In the Primary Cohort, baseline Z-score showed a significant non-linear (U-shaped) association with subsequent growth in GAMs (p<0.001), with higher growth for small (Z<0) and severely dilated (Z>5) aortas. The size-growth relationship was significantly moderated by age, sex, blood pressure. In the Sub-Cohort, phenotype distribution was: Stable 50.4% (532/1,055), Stable-with-Noise 21.6% (228/1,055), Continuous 5.4% (57/1,055), and Discontinuous/Episodic 22.6% (238/1,055). Among patients with Total Growth ≥2.0 mm (n=295), 81% (238/295) were episodic and 58.3% (172/295) had a non-dilated baseline aorta (Z<2). Conclusion The cohort-level size–growth relationship is non-linear, and episodic growth behavior dominates among those that enlarge. These findings support reassessing surveillance intervals, risk communication, and threshold-based decision pathways in thoracic aortic disease.
No takes yet. Share an insight, caveat, or question.
Jorge et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: